Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Cardiovascular Emerging Evidence Evidence Rating: Emerging (Preliminary animal data) Cardiovascular applications are less studied but intriguing: Cardiac protection Arrhythmia prevention Blood vessel healing Collateral vessel formation Regulatory Status FDA Classification BPC-157 is not approved by the FDA for any medical use in humans
For example, research on B12-deficient individuals indicates significant improvements in memory and attention span with regular supplementation
Property Detail Full Name Body Protection Compound 157 Amino Acids 15 (pentadecapeptide) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1,419 g/mol Forms reviewed by FDA Free base and acetate salt FDA Status Not approved Active IND applications None (as of April 2026) Compounding status Under reclassification review (July 23-24, 2026) Is BPC-157 FDA Approved in 2026
Supplies Needed Unlike the injectable peptides catalogued elsewhere on this site, Dihexa is strongly lipophilic and poorly water-soluble , so it is not reconstituted with bacteriostatic water into a sterile solution
US$ 20.78
US$ 24.39
US$ 20.51
US$ 21.20
US$ 29.62